Your browser doesn't support javascript.
loading
Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma.
Chung, Hye Yoon; Shin, Ha Young; Choi, Young-Chul; Park, Hyung Jun; Lee, Jin Gu; Lee, Chang Young; Park, Byung Jo; Kim, Gi Jeong; Kim, Seung Woo.
Afiliação
  • Chung HY; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Shin HY; Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, Korea.
  • Choi YC; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Park HJ; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Lee JG; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Lee CY; Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • Park BJ; Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • Kim GJ; Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • Kim SW; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Eur J Neurol ; 31(2): e16119, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37909803
ABSTRACT
BACKGROUND AND

PURPOSE:

Germinal centers (GCs) can be observed in the thymic tissues of patients with thymoma-associated myasthenia gravis (MG). Although an association between thymic GCs and MG has been suggested, it is unknown whether the presence of GCs could predict the development of MG after the resection of thymoma, known as postthymectomy MG.

METHODS:

We conducted a retrospective analysis of previously nonmyasthenic patients who underwent surgical removal of the thymoma. All available thymic tissue slides were rereviewed by a pathologist to assess for GCs. Patients were classified into GC-positive and GC-negative groups based on the presence of GCs. The incidence of postthymectomy MG was compared between the two groups, and the risk factors for postthymectomy MG were assessed.

RESULTS:

Of the 196 previously nonmyasthenic patients who underwent thymoma resection, 21 were GC-positive, whereas 175 were GC-negative. Postthymectomy MG developed in 11 (5.6%) patients and showed a higher incidence in the GC-positive group than in the GC-negative group (33.3% vs. 2.3%, p < 0.001). No postoperative radiotherapy and the presence of GCs were risk factors for postthymectomy MG in the univariate analysis. In multivariate analysis, invasive thymoma (hazard ratio [HR] = 9.835, 95% confidence interval [CI] = 1.358-105.372), postoperative radiotherapy (HR = 0.160, 95% CI = 0.029-0.893), and presence of GCs (HR = 15.834, 95% CI = 3.742-67.000) were significantly associated with postthymectomy MG.

CONCLUSIONS:

Thymic GCs may be a significant risk factor for postthymectomy MG. Even in patients with thymoma who do not show clinical symptoms of MG, postthymectomy MG should be considered, especially if thymic GCs are observed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Miastenia Gravis Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Miastenia Gravis Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article
...